Showing 1 - 11 results of 11 for search 'G. A. Belitsky', query time: 0.05s Refine Results
  1. 1
    Mechanisms of carcinogenesis prevention by flavonoids

    Mechanisms of carcinogenesis prevention by flavonoids by G. A. Belitsky, K. I. Kirsanov, E. A. Lesovaya, M. G. Yakubovskaya

    Published 2015-06-01
    Get full text
    Article
  2. 2
    Mechanisms of the carcinogenicity of nanomaterials

    Mechanisms of the carcinogenicity of nanomaterials by G. A. Belitsky, K. I. Kirsanov, E. A. Lesovaya, M. G. Yakubovskaya

    Published 2022-12-01
    Get full text
    Article
  3. 3
    Trabectedin – the DNA minor groove binder

    Trabectedin – the DNA minor groove binder by G. A. Belitsky, K. I. Kirsanov, E. A. Lesovaya, M. G. Yakubovskaya

    Published 2015-06-01
    Get full text
    Article
  4. 4
    Anti-cancer activity of сuraxin CBL0137 on the models of acute leukemia in vitro

    Anti-cancer activity of сuraxin CBL0137 on the models of acute leukemia in vitro by T. I. Fetisov, K. I. Kirsanov, A. A. Borunova, M. N. Zatsepina, E. A. Lesovaya, T. N. Zabotina, G. A. Belitsky, M. G. Yakubovskaya

    Published 2019-12-01
    Get full text
    Article
  5. 5
    Influence of DNA-binding compounds with cancer preventive activity on the mechanisms of gene expression regulation

    Influence of DNA-binding compounds with cancer preventive activity on the mechanisms of gene expression regulation by K. I. Kirsanov, O. A. Vlasova, T. I. Fetisov, R. G. Zenkov, E. A. Lesovaya, G. A. Belitsky, K. Gurova, M. G. Yakubovskaya

    Published 2019-01-01
    Get full text
    Article
  6. 6
    Autophagy activation in breast cancer cells in vitro after the treatment with PI3K/AKT/mTOR inhibitors

    Autophagy activation in breast cancer cells in vitro after the treatment with PI3K/AKT/mTOR inhibitors by D. D. Grigoreva, E. M. Zhidkova, E. S. Lylova, A. D. Enikeev, K. I. Kirsanov, G. A. Belitsky, M. G. Yakubovskaya, E. A. Lesovaya

    Published 2022-12-01
    Get full text
    Article
  7. 7
    Inhibition of glucocorticoid-induced REDD1 expression by rapamycin in breast cancer cells

    Inhibition of glucocorticoid-induced REDD1 expression by rapamycin in breast cancer cells by D. D. Grigorieva, E. M. Zhidkova, E. S. Lylova, D. V. Demina, K. I. Kirsanov, G. A. Belitsky, M. G. Yakubovskaya, E. A. Lesovaya

    Published 2022-03-01
    Get full text
    Article
  8. 8
    Modern approaches for the screening of epigenetically active xenobiotics

    Modern approaches for the screening of epigenetically active xenobiotics by V. P. Maksimova, P. E. Bugaeva, E. M. Zhidkova, O. G. Usalka, E. A. Lesovaya, G. A. Belitsky, M. G. Yakubovskaya, K. I. Kirsanov

    Published 2019-11-01
    Get full text
    Article
  9. 9
    Determination of chemoresistance of ovarian cancer cells in vitro

    Determination of chemoresistance of ovarian cancer cells in vitro by K. A. Kuzin, T. I. Fetisov, R. I. Knyazev, L. Ya. Fomina, L. V. Meheda, E. A. Lesovaya, G. A. Belitsky, M. G. Yakubovskaya, K. I. Kirsanov

    Published 2019-12-01
    Get full text
    Article
  10. 10
    Activation of interferon-α signaling by resveratrol, genistein and quercetin

    Activation of interferon-α signaling by resveratrol, genistein and quercetin by O. A. Vlasova, A. A. Borunova, A. Safina, I. V. Smetanina, E. A. Lesovaya, G. A. Belitsky, T. N. Zabotina, K. Gurova, K. I. Kirsanov, M. G. Yakubovskaya

    Published 2019-02-01
    Get full text
    Article
  11. 11
    EPIGENETIC EFFECTS OF ENZASTAURIN – A NEW ASPECT IN THE MECHANISM OF ACTION OF AN ANTICANCER DRUG FROM PROTEIN KINASE INHIBITORS

    EPIGENETIC EFFECTS OF ENZASTAURIN – A NEW ASPECT IN THE MECHANISM OF ACTION OF AN ANTICANCER DRUG FROM PROTEIN KINASE INHIBITORS by V. P. Maksimova, J. V. Makus, O. G. Usalka, E. S. Lylova, P. E. Bugaeva, E. M. Zhidkova, D. A. Fedorov, O. P. Lizogub, E. A. Lesovaya, G. A. Belitsky, M. G. Yakubovskaya, K. I. Kirsanov

    Published 2020-09-01
    Get full text
    Article

Search Tools: